Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune System Modulation by Enhanced vs Standard Prehabilitation Program in Patients Undergoing Elective Major Surgery - a Prospective Monocentric Randomized Single-blinded Controlled Trial

NCT04498208 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04498208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04498208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune System Modulation by Enhanced vs Standard Prehabilitation Program in Patients Undergoing Elective Major Surgery - a Prospective Monocentric Randomized Single-blinded Controlled Trial
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
October 7, 2020
Completion date
April 21, 2024
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal disease, gynecologic disease, immune system and related disorders, preoperative care, surgery, thoracic diseases, urological disease